News from our newspaper # February 24 , Chairman Jiang Xiaomeng of the Group Company presided over the meeting of the 11th Board of Directors of the Company, deliberating and passing 2020 Annual Board of Directors Report, 2020 General Manager Business Report, 2020 Annual Report and other 15 related reports and proposals. The 10th 2 Supervisory Board of the Company was also held on the same day.

Due to the new coronary pneumonia epidemic, the national cement industry was greatly affected in the short term, but the overall operation of the industry was stable throughout the year. 2020 , the company made new progress in the construction of cement projects. The off-site technological transformation project (with waste heat power generation) of the new dry cement production line with a daily output of 4500 tons of clinker in Huangping, Guizhou was completed and put into trial production in 9 . The production license was successfully obtained during the year. All production and operation indexes of the production line basically reached the expected targets. The cement enterprises under the company actively carry out benchmarking management and standardized management, continuously promote the "three reductions and three improvements" activities, steadily implement various technological transformation work, and continuously improve the production efficiency of enterprises while strictly controlling production costs. A total of ,526 tons of cement and clinker were sold throughout the year. Daye Peak has implemented more than 10 technical reforms such as the technical reform of the newly added raw meal online analyzer, the technical reform of the grate cooler, the transformation of the cement mill system, and the transformation of the waste heat power generation DCS . The quality of raw meal has been significantly improved and the standard coal consumption per ton of clinker has decreased. Yunnan Peak has completed the technical renovation of grate cooler, preheater and other equipment, effectively increasing the output of rotary kiln. In addition, the company integrated part of the equity participation in the cement business and sold the equity of Guangxi Huying; participated in the major asset reorganization of Tianshan shares with the equity of Southern Cement held by the company, further optimizing the asset allocation structure.

, the reform of the pharmaceutical industry continued to increase, the industry pattern further changed. Jianfeng Pharmaceutical and its subsidiaries further strengthened product research and development and innovation. Paroxetine Hydrochloride Tablets passed the consistency evaluation and obtained the production approval documents of esomeprazole sodium raw materials and injections. Subsidiaries Jianfeng Yien and Zhejiang Erying respectively obtained the clinical approval documents of Class I anti-tumor new drug JFAN-1001 and Class III new drug acetaminophen suppository. Jianfeng Pharmaceutical and its subsidiaries have made progress in a number of technological transformation and engineering construction. The annual output of 20 .6 billion solid preparations (internationalization) project in Jinxi Production Base of Jianfeng Pharmaceutical has been included in the key technological transformation project of Jinhua City in 2020 . At present, the civil work of the main project has been basically completed, and equipment installation and debugging, quality system introduction and verification are underway. New North Card and New Peak North Card have fully implemented technical transformation, on the basis of its existing pesticides and pharmaceutical intermediates, it will be upgraded to become a comprehensive R & D and production base for APIs, pharmaceutical intermediates and pesticides, and actively promote the industrial upgrading strategy of the integration of APIs and preparations of Jianfeng Pharmaceutical. Peak Pharmaceutical is also actively exploring new marketing models, further improving the commission-based marketing model and incentive assessment system.

In addition, under continued market regulation, the image of the health care industry and consumer trust have recovered, and under the influence of the new crown epidemic, national health care awareness has been growing and demand for health care products has gradually recovered. Subsidiaries Jianfeng Health, Tianjin Jianfeng Natural Products and Tianjin Flanders have all passed the national high-tech enterprise certification; Jianfeng Health has newly added health food registration approval documents, realizing the customized sales and product development of multiple functional foods; Tianjin Jianfeng Natural Products has updated and optimized the product technology, effectively reducing the production cost; tianjin Flanders has obtained production licenses for special dietary foods (nutritional supplements for pregnant women and lactating mothers) and convenience foods (instant cereals), realizing product transformation. Jianfeng International Trade readjusted the layout of the warehouse base, completed the construction of two new logistics warehouses, further improved the land utilization rate and increased the operation and storage area, and made full use of the storage and transportation advantages of Jinhua South Station to effectively improve the storage and operation capacity. Peak cable through the adjustment of product structure, pay attention to the maintenance and training of large customers, the annual production and sales, profits have increased year-on-year. On the day of

2 meeting of the 10th board of supervisors, deliberating and approving 5 related reports and proposals such as the company's 2020 annual board of supervisors report, 2020 annual financial final accounts report, 2020 annual profit distribution plan, etc. (residual fruit)